Rejiv Rajendranath
Overview
Explore the profile of Rejiv Rajendranath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghafur A, Balaguru P, Ramanan S, Rajendranath R, Raj R, Zehran M, et al.
Infect Control Hosp Epidemiol
. 2024 Jan;
45(5):677-680.
PMID: 38173359
In an Indian oncology setting, between August and December 2021, 56 patients, developed bacteremia. An investigation revealed a contaminated batch of the antiemetic drug palonosetron. The outbreak was terminated by...
2.
Panda S, Radhakrishnan V, Ganesan P, Rajendranath R, Ganesan T, Rajalekshmy K, et al.
Indian J Hematol Blood Transfus
. 2020 May;
36(2):300-308.
PMID: 32425381
Presence of minimal residual disease (MRD) following induction chemotherapy is a well-recognized risk factor to predict relapse in acute lymphoblastic leukemia (ALL). There is paucity of data on MRD and...
3.
Rajappa S, Joshi A, Doval D, Batra U, Rajendranath R, Deo A, et al.
Oncol Lett
. 2018 Aug;
16(3):3757-3769.
PMID: 30127986
The management of breast cancer with advanced disease or metastasis is a common problem in India and other countries. A panel of 13 oncology experts deliberated on the sidelines of...
4.
Murali A, Radhakrishnan V, Ganesan T, Rajendranath R, Ganesan P, Selvaluxmy G, et al.
J Glob Oncol
. 2017 Nov;
3(5):459-468.
PMID: 29094084
Purpose: Lung cancer is the most common cause of cancer mortality in the world. There are limited studies on survival outcomes of lung cancer in developing countries such as India....
5.
Mishra S, Radhakrishnan V, Ganesan P, Rajendranath R, Rajaraman S, Ganesan T, et al.
Indian J Hematol Blood Transfus
. 2017 Oct;
33(4):470-476.
PMID: 29075056
Identification of baseline parameters that predict chemotherapy related morbidities in elderly lymphoma patients can help in tailoring treatment. However, there is a paucity of tools to predict the risk of...
6.
Udupa K, Rajendranath R, Sagar T, Thomas J
Indian J Med Paediatr Oncol
. 2017 May;
38(1):15-17.
PMID: 28469331
Introduction: Erlotinib and gefitinib are the most commonly used epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in the treatment of EGFR mutant nonsmall cell lung cancer (NSCLC). Both erlotinib and...
7.
Radhakrishnan V, Thampy C, Ganesan P, Rajendranath R, Ganesan T, Rajalekshmy K, et al.
Indian J Hematol Blood Transfus
. 2016 Jul;
32(3):257-61.
PMID: 27429516
There is paucity of data in pediatric Acute Myeloid Leukemia (AML) from developing countries. We analyzed the outcomes of 65 consecutive patients with pediatric AML treated at our centre from...
8.
Unnikrishnan R, Veeraiah S, Mani S, Rajendranath R, Rajaraman S, Vidhubala Elangovan G, et al.
Clin Lymphoma Myeloma Leuk
. 2016 Apr;
16(6):366-371.e3.
PMID: 27052853
Background: Adherence to oral therapy over a long period is important for optimal outcomes in chronic myeloid leukemia (CML). Methods: Patients in the chronic phase of CML (taking imatinib for...
9.
Shah A, Ganesan P, Radhakrishnan V, Kannan K, Rajendranath R, Mahajan V, et al.
Indian J Med Paediatr Oncol
. 2016 Apr;
37(1):53-8.
PMID: 27051159
Background: Antifungal prophylaxis (AFP) reduces the incidence of invasive fungal infections (IFIs) during induction therapy of acute myeloid leukemia (AML). Posaconazole is considered the standard of care. Voriconazole, a generic...
10.
Radhakrishnan V, Gupta S, Ganesan P, Rajendranath R, Ganesan T, Rajalekshmy K, et al.
Indian J Med Paediatr Oncol
. 2016 Jan;
36(4):261-4.
PMID: 26811597
Background: There is a paucity of data on the outcome following the treatment for acute lymphoblastic leukemia (ALL) from developing countries. Materials And Methods: Two hundred and thirty-eight consecutive patients...